Sun Pharmaceutical Industries (Australia) Pty Ltd

Australia

Back to Profile

1-19 of 19 for Sun Pharmaceutical Industries (Australia) Pty Ltd Sort by
Query
Aggregations
Jurisdiction
        United States 14
        World 5
Date
2025 September 1
2025 (YTD) 2
2024 1
2023 1
2022 2
See more
IPC Class
C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells 15
C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants 10
C12N 9/02 - Oxidoreductases (1.), e.g. luciferase 9
C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin 8
A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy 4
See more
Status
Pending 3
Registered / In Force 16
Found results for  patents

1.

PROCESS

      
Application Number 18276606
Status Pending
Filing Date 2022-02-09
First Publication Date 2025-09-11
Owner Sun Pharmaceutical Industries Australia Pty Limited (Australia)
Inventor
  • Li, Xu
  • Gras, Sally Louise
  • Spencer, Garrick Westley Kyle

Abstract

The disclosure relates to a biotransformation for the manufacture of one or more opiate or opioid alkaloids using a crude poppy extract or a purified or semi-purified source of opiate or opioid alkaloid; vectors comprising nucleic acid molecules encoding enzymes; microbial cells expressing nucleic acids encoding said enzymes and including modified enzymes with enhanced activity.

IPC Classes  ?

  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

2.

A METHOD FOR EXTRACTION OF ALKALOID

      
Application Number 18726938
Status Pending
Filing Date 2023-01-05
First Publication Date 2025-06-12
Owner SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (Australia)
Inventor
  • Stevens, Geoffrey Wayne
  • Mumford, Kathryn Anne
  • Li, Wen
  • Wu, Yue
  • Thuan Lu, Hiep
  • Vovers, Jessica Indah

Abstract

The present invention provides a liquid-liquid extraction process for the extraction of alkaloids from a source, using an alkyl phosphine oxide of Formula A (as described herein) as an extractant in combination with a diluent selected from xylene or limonene; wherein the method comprises the step of contacting the aqueous solution of alkaloid source with an organic layer consisting of an alkyl phosphine oxide of Formula A as extractant and a diluent selected from xylene or limonene.

IPC Classes  ?

  • C07D 489/02 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

3.

TRANSCRIPTION FACTOR

      
Application Number 18563183
Status Pending
Filing Date 2022-05-24
First Publication Date 2024-07-18
Owner SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (Australia)
Inventor
  • Graham, Ian
  • Winzer, Thilo

Abstract

The disclosure relates to transcription cassettes and vectors comprising a nucleotide sequence encoding a transcription factor; plants, plant cells, plant cell cultures and seeds that are genetically engineered to include a recombinant copy or copies of the nucleic acid encoding said transcription factor; and processes for the extraction of benzylisoquinoline alkaloids from the genetically engineered plants.

IPC Classes  ?

  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C07D 489/02 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12P 17/12 - Nitrogen as only ring hetero atom containing a six-membered hetero ring

4.

A METHOD FOR EXTRACTION OF ALKALOID

      
Application Number AU2023050002
Publication Number 2023/130158
Status In Force
Filing Date 2023-01-05
Publication Date 2023-07-13
Owner SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (Australia)
Inventor
  • Stevens, Geoffrey, Wayne
  • Mumford, Kathryn, Anne
  • Li, Wen
  • Wu, Yue
  • Thuan Lu, Hiep
  • Vovers, Jessica, Indah

Abstract

The present invention provides a liquid-liquid extraction process for the extraction of alkaloids from a source, using an alkyl phosphine oxide of Formula A (as described herein) as an extractant in combination with a diluent selected from xylene or limonene; wherein the method comprises the step of contacting the aqueous solution of alkaloid source with an organic layer consisting of an alkyl phosphine oxide of Formula A as extractant and a diluent selected from xylene or limonene.

IPC Classes  ?

  • C07B 63/00 - PurificationSeparation specially adapted for the purpose of recovering organic compoundsStabilisationUse of additives
  • B01D 11/04 - Solvent extraction of solutions which are liquid
  • C07D 489/02 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
  • C07F 9/53 - Organo-phosphine oxidesOrgano-phosphine sulfides

5.

TRANSCRIPTION FACTOR

      
Application Number IB2022054862
Publication Number 2022/249068
Status In Force
Filing Date 2022-05-24
Publication Date 2022-12-01
Owner SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (Australia)
Inventor
  • Graham, Ian
  • Winzer, Thilo

Abstract

The disclosure relates to transcription cassettes and vectors comprising a nucleotide sequence encoding a transcription factor; plants, plant cells, plant cell cultures and seeds that are genetically engineered to include a recombinant copy or copies of the nucleic acid encoding said transcription factor; and processes for the extraction of benzylisoquinoline alkaloids from the genetically engineered plants.

IPC Classes  ?

  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • A01H 1/00 - Processes for modifying genotypes
  • A01H 6/64 - Papaveraceae, e.g. poppy
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants

6.

PROCESS

      
Application Number AU2022050077
Publication Number 2022/170385
Status In Force
Filing Date 2022-02-09
Publication Date 2022-08-18
Owner SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (Australia)
Inventor
  • Li, Xu
  • Gras, Sally, Louise
  • Spencer, Garrick, Westley, Kyle

Abstract

The disclosure relates to a biotransformation for the manufacture of one or more opiate or opioid alkaloids using a crude poppy extract or a purified or semi-purified source of opiate or opioid alkaloid; vectors comprising nucleic acid molecules encoding enzymes; microbial cells expressing nucleic acids encoding said enzymes and including modified enzymes with enhanced activity.

IPC Classes  ?

  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

7.

Plant cytochrome P450

      
Application Number 17084878
Grant Number 11312973
Status In Force
Filing Date 2020-10-30
First Publication Date 2021-04-01
Grant Date 2022-04-26
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo Hans
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • A01H 3/04 - Processes for modifying phenotypes by treatment with chemicals
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/67 - General methods for enhancing the expression
  • C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

8.

Plant cytochrome P450

      
Application Number 16266525
Grant Number 10844391
Status In Force
Filing Date 2019-02-04
First Publication Date 2019-05-30
Grant Date 2020-11-24
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo Hans
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • A01H 3/04 - Processes for modifying phenotypes by treatment with chemicals
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/67 - General methods for enhancing the expression
  • C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

9.

Papaver somniferum cytochrome P450

      
Application Number 15469731
Grant Number 10385354
Status In Force
Filing Date 2017-03-27
First Publication Date 2017-12-28
Grant Date 2019-08-20
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo Hans
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.

IPC Classes  ?

  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • A01H 3/04 - Processes for modifying phenotypes by treatment with chemicals
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/67 - General methods for enhancing the expression
  • C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

10.

MODIFIED PLANT

      
Application Number GB2017050068
Publication Number 2017/122011
Status In Force
Filing Date 2017-01-12
Publication Date 2017-07-20
Owner SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (Australia)
Inventor
  • Winzer, Thilo
  • Walker, Tracy Carol
  • Meade, Fergus
  • Larson, Tony Robert
  • Graham, Ian Alexander

Abstract

The disclosure relates to modified plants of the genus Papaver comprising two or more genes encoding codeine (O)-demethylase (CODM) wherein the modified plants have modified alkaloid content when compared to unmodified plants wherein the alkaloid content has a high codeine phenotype.

IPC Classes  ?

  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

11.

Cytochrome P450 fusion protein

      
Application Number 15304455
Grant Number 10006010
Status In Force
Filing Date 2015-05-15
First Publication Date 2017-03-02
Grant Date 2018-06-26
Owner
  • The University of York (United Kingdom)
  • Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo
  • Graham, Ian
  • Walker, Tracy Carol

Abstract

Papaver somniferum [P. somniferum] cultivar, transgenic cells transformed with said nucleic acid molecule and sequence variants thereof; and including methods for the production of intermediates in the production of morphinans.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12P 17/12 - Nitrogen as only ring hetero atom containing a six-membered hetero ring
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

12.

Biosynthesis of opiate alkaloids

      
Application Number 15182761
Grant Number 09862979
Status In Force
Filing Date 2016-06-15
First Publication Date 2016-09-29
Grant Date 2018-01-09
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo
  • Graham, Ian Alexander
  • Walker, Tracy Carol

Abstract

Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.

IPC Classes  ?

  • C12N 15/00 - Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor
  • C12N 9/04 - Oxidoreductases (1.), e.g. luciferase acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
  • C12N 9/10 - Transferases (2.)
  • C12N 5/04 - Plant cells or tissues
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • C12P 21/06 - Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy
  • C07H 21/04 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12N 15/52 - Genes encoding for enzymes or proenzymes
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 9/18 - Carboxylic ester hydrolases

13.

Plant cytochrome P450

      
Application Number 14884448
Grant Number 09725732
Status In Force
Filing Date 2015-10-15
First Publication Date 2016-02-04
Grant Date 2017-08-08
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

14.

NOVEL CYTOCHROME P450 FUSION PROTEIN

      
Application Number GB2015051446
Publication Number 2015/173590
Status In Force
Filing Date 2015-05-15
Publication Date 2015-11-19
Owner
  • THE UNVERSITY OF YORK (United Kingdom)
  • SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LIMITED (Australia)
Inventor
  • Winzer, Thilo
  • Graham, Ian
  • Walker, Tracy Carol

Abstract

This disclosure relates to the isolation of a nucleic acid molecule[s] that encode a novel cytochrome P450 and an oxidoreductase from a Papaver somniferum [P. somniferum] cultivar, transgenic cells transformed with said nucleic acid molecule and sequence variants thereof; and including methods for the production of intermediates in the production of morphinans.

IPC Classes  ?

  • C12N 5/04 - Plant cells or tissues
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/53 - Oxidoreductases (1)
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

15.

Biosynthesis of opiate alkaloids

      
Application Number 14375120
Grant Number 09447444
Status In Force
Filing Date 2013-03-12
First Publication Date 2015-01-01
Grant Date 2016-09-20
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Australia)
Inventor
  • Winzer, Thilo
  • Graham, Ian Alexander
  • Walker, Tracy Carol

Abstract

Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.

IPC Classes  ?

  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12N 9/04 - Oxidoreductases (1.), e.g. luciferase acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
  • C12N 9/10 - Transferases (2.)
  • C12N 9/18 - Carboxylic ester hydrolases
  • C12N 5/04 - Plant cells or tissues
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy
  • C07H 21/04 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12N 15/52 - Genes encoding for enzymes or proenzymes

16.

Plant cytochrome P450

      
Application Number 13806608
Grant Number 09200261
Status In Force
Filing Date 2011-07-18
First Publication Date 2013-05-23
Grant Date 2015-12-01
Owner SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (Australia)
Inventor
  • Winzer, Thilo
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants

17.

Methyltransferase nucleic acids and polypeptides

      
Application Number 13806310
Grant Number 09458481
Status In Force
Filing Date 2011-06-16
First Publication Date 2013-04-25
Grant Date 2016-10-04
Owner Sun Pharmaceutical Industries (Australia) Pty Ltd (Austria)
Inventor
  • Winzer, Thilo Hans
  • Walker, Tracy Carol
  • Graham, Ian Alexander

Abstract

Papaver somniferum cultivar; and uses in the production of noscapine and identification of poppy cultivars that include the genes that include these nucleic acid molecules.

IPC Classes  ?

  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants
  • C12P 17/18 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
  • C12N 9/10 - Transferases (2.)
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells

18.

Method of altering the alkaloid composition in poppy plants

      
Application Number 11568651
Grant Number 08377851
Status In Force
Filing Date 2005-05-06
First Publication Date 2009-03-19
Grant Date 2013-02-19
Owner SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (Australia)
Inventor Cotterill, Paul

Abstract

The method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of acylcyclohexanedione compound or agriculturally acceptable salt thereof to said poppy plant or locus thereof. Further, the present invention also provides the method of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of methyl jasmonate or agriculturally acceptable salt thereof to said poppy plant or locus thereof.

IPC Classes  ?

  • A01N 43/40 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
  • A01N 37/08 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing carboxylic groups or thio-analogues thereof, directly attached by the carbon atom to a cycloaliphatic ringDerivatives thereof
  • C07D 489/00 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

19.

Methods of altering poppy characteristics

      
Application Number 12064429
Grant Number 08557737
Status In Force
Filing Date 2006-08-17
First Publication Date 2008-10-30
Grant Date 2013-10-15
Owner SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (Australia)
Inventor Cotterill, Paul

Abstract

The present invention relates to the use of sulfonylurea compounds to alter physical and/or growth characteristics of poppy plants.

IPC Classes  ?

  • A01N 47/36 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the group N—CO—N directly attached to at least one heterocyclic ringThio-analogues thereof